The proceeds will aid Qualifyze in improving its cloud-based audit data and application platform. Credit: Qualifyze.

German compliance company Qualifyze has secured $12m in a financing round to improve supply chain compliance in the pharmaceutical sector using technological and audit data.

The funding round saw participation from current investors HV Capital and Rheingau Founders. New investors HarbourVest Partners and H14 also took part.

The company plans to expedite its transformation into an end-to-end supply chain compliance data platform. 

Established in 2019, Qualifyze offers supply chain compliance assessments to pharmaceutical companies.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The proceeds will aid the company in improving its cloud-based audit data and application platform that links auditors, customers and suppliers. These solutions enable tracking, observation and adherence to quality and sustainability compliance in the pharmaceutical industry.

See Also:

Qualifyze’s supplier intelligence suite offers supplier compliance level statistics and audit data to pharmaceutical firms. This helps forecast trends and create compliance risk mitigation approaches.

The company also intends to use the additional funds to expand its footprint in existing and new markets geographically.

Qualifyze CEO and founder Dr David Schneider stated: “Qualifyze is creating a new category of compliance data, which will allow our clients to make more informed decisions to increase drug safety for their patients and to better allocate investments into supply chain compliance, even beyond GxP [good practice]. 

“This funding will help us accelerate our mission to transform supply chain compliance in healthcare in a sustainable, data-driven manner.”